CHChynna Huang

Chynna Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chynna Huang has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sputum Cellularity and MRI Ventilation Defects in Severe Asthma

    by Hana Serajeddini, Ashutosh Thakar, Melanie Kjarsgaard, Chynna Huang, Nandhitha Ragunayakam, Ekamdeep Sandhu, Carmen Venegas Garrido, Yonni Friedlander, Norm Konyer, Kayla Zhang, et al.


  • Effect of dupilumab on sputum eosinophils in patients with moderate‐to‐severe asthma

    by Sarah Svenningsen, Melanie Kjarsgaard, Kayla Zhang, Hana Serajeddini, Carmen Venegas Garrido, Anurag Bhalla, Katherine Radford, Chynna Huang, Terence Ho, Nandhitha Ragunayakam, et al.


  • Non-T2 cytokines post Benralizumab associate with residual symptoms

    by Manali Mukherjee, Chynna Huang, Kayla Zhang, Xiaotian Ju, Melanie Kjarsgaard, Carmen Venegas-Garrido, Katherine Radford, Anurag Bhalla, Kiho Son, Sylvia Lauks, et al.

    Rationale: Despite depletion of blood and sputum eosinophils by benralizumab, a subset of patients remain symptomatic (asthma control questionnaire, ACQ-5≥1.5). Objective: To investigate cytokines associated with residual symptoms post-benralizumab. Method: Sputum was assessed for cytokines (EllaTM,Protein Simple) collected at baseline (V1), after placebo (V3), and 5 injections of benralizumab (V10) in 20 severe asthma patients (11 females, 57±13 years) recruited in a sequential placebo-controlled trial (NCT03470311), previously uncontrolled (ACQ 1.5; sputum eos 3%) on mepolizumab/reslizumab. Results: Benralizumab allowed significant decrease in sputum IL-13 (Fig 1A), but increases in IL-6 and TNFa compared to V1, irrespective of ACQ-5 and fractional exhaled nitric oxide (FENO). At V10, optimal response, marked by ACQ-50.05, Mann-Whitney). Increased IL-18 and decreased IL-15 were observed in PR subgroup that further correlated with ACQ-5 (Fig 1B-C). In PR group, n=4 with no improvement (ACQ,V10:2.1±0.6;V10-V1:+0.5±6) had CT mucus plugging. Conclusions: Residual symptoms despite depleted eosinophils post benralizumab may be associated with non-T2 cytokines linked to inflammasome activation (IL-18), reduced NK cell activation (IL-15), and mucus plugging.

  • Charcot-Leyden crystals are associated with airway autoimmune responses in severe asthma

    by Kiho Son, Kayla Zhang, Raquel Lopez, Aswathi Nair, Emily Volfson, Katherine Radford, Nicola Calma, Melanie Kjarsgaard, Chynna Huang, Parameswaran Nair, et al.

    Rationale: Airway autoantibodies induce histone-coated eosinophil extracellular traps (EETs). EETs are associated with free eosinophil granules (FEGs) and galectin-10 which autocrystallize ex vivo to form Charcot-Leyden crystals (CLCs). Objective: To investigate cytokines and autoimmune responses in patients with CLCs. Methods: Between 2020-2022, CLCs and cell differentials were routinely reported for processed sputum. Cell-free supernatants were assessed for antinuclear antibodies (HUMAN Diagnostics, PMID 28751233), cytokines (EllaTM, Protein Simple), and danger-associated molecular patterns (DAMPs): high mobility box group 1 (HMGB1) and galectin-10 proteins (Novus Biologicals). Results: CLCs were reported in 61/3075 (2%) processed sputa slides (protocol: PMID 8804934). All 46 CLC+ samples with adequate volume and confirmed severe asthma diagnosis were eosinophilic (≥3% eos±FEGs) and comprised the Eos+CLC+ group. Additionally, Eos+CLC- (n=53) and Eos-CLC- (n=32) were included for analysis. Eos+CLC+ had increased ANAs vs CLC- groups (P+CLC+ (96%) vs. Eos-CLC- (30%) (Fig 1B). Eos+CLC+ had higher T2 inflammation (IL-4, IL-5, IL-13, P- sputa. Conclusions: We report that severe asthma patients with CLCs have high autoimmune burden marked by DAMPs and autoantibodies.


  • Assessment of eosinophilic airway inflammation using formalin-fixed, paraffin-embedded sputum plugs

    by Zil Patel, Nadia Suray Tan, Alex Huynh, Nicola Calma, Katherine Radford, Snehal Somalwar, Chynna Huang, Melanie Kjarsgaard, Anmar Ayoub, Parameswaran Nair, et al.

    Background: Sputum cytology via clinical dithiothreitol processing is a well-accepted, reproducible method to assess airway eosinophilia (PMID:10673188). However, this multi-step protocol (~1 hour) requires trained personnel and dedicated space, limiting its routine use in clinical practice. Aims: We evaluated the feasibility and validity of using formalin-fixed, paraffin-embedded (FFPE) sputum plugs as a simplified, efficient (~10 min.) method to assess airway eosinophilia. Methods: After clinical processing, excess sputum plugs (~100mg) from 50 patients with airway disease were fixed in 10% formalin overnight, and paraffin embedded. FFPE blocks were sectioned, stained with hematoxylin and eosin, and counted by four observers including two sputum technologists. Mean eosinophil counts were expressed as a percentage of total cells counted and compared with clinical differentials. Results: 48 out of 50 (96%) FFPE sputum plugs were adequate for cell differentials (>400 cells). Eosinophil counts between the two methods were similar (p=0.15, paired t-test, ns), significantly correlated (ρ=0.91, Spearman, P<0.0001) and in agreement (mean/SD on Bland Altman -1.10 7.31). The FFPE method detected airway eosinophilia (AUC ROC 0.95, p2.3%) showed positive anti-eosinophil peroxidase immunostaining. Conclusion: FFPE sputum plugs as a “biopsy tissue block” are feasible for detecting airway eosinophilia, and non-inferior to clinical protocol. Further validation in a healthy cohort is underway.

  • Open Access

    Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease

    by Terence Ho, Matthew Nichols, Gayatri Nair, Katherine Radford, Melanie Kjarsgaard, Chynna Huang, Anurag Bhalla, Nicola Lavigne, Manali Mukherjee, Michael Surette, et al.

    Background: Excess pulmonary iron has been implicated in the pathogenesis of lung disease, including asthma and COPD. An association between higher iron content in sputum macrophages and infective exacerbations of COPD has previously been demonstrated. Objectives: To assess the mechanisms of pulmonary macrophage iron sequestration, test the effect of macrophage iron-loading on cellular immune function, and prospectively determine if sputum hemosiderin index can predict infectious exacerbations of COPD. Methods: Intra- and extracellular iron was measured in cell-line-derived and in freshly isolated sputum macrophages under various experimental conditions including treatment with exogenous IL-6 and hepcidin. Bacterial uptake and killing were compared in the presence or absence of iron-loading. A prospective cohort of COPD patients with defined sputum hemosiderin indices were monitored to determine the annual rate of severe infectious exacerbations. Results: Gene expression studies suggest that airway macrophages have the requisite apparatus of the hepcidin-ferroportin axis. IL-6 and hepcidin play roles in pulmonary iron sequestration, though IL-6 appears to exert its effect via a hepcidin-independent mechanism. Iron-loaded macrophages had reduced uptake of COPD-relevant organisms and were associated with higher growth rates. Infectious exacerbations were predicted by sputum hemosiderin index (β = 0.035, p = 0.035). Conclusions: We demonstrate in-vitro and population-level evidence that excess iron in pulmonary macrophages may contribute to recurrent airway infection in COPD. Specifically, IL-6-dependent iron sequestration by sputum macrophages may result in immune cell dysfunction and ultimately lead to increased frequency of infective exacerbation.


  • Open Access

    Sex Differences in Type 2 Innate Lymphoid Cells in Adult Asthmatics

    by Michael J. Aw, Parameswaran K. Nair, Brittany Salter, Ruchong Chen, Kentaro Machida, Mark D. Inman, Chynna Huang, Melanie Kjarsgaard, Katherine Radford, Paul M. O'Byrne, et al.

  • Top Cited Papers

    Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia

    by Steven G. Smith, Ruchong Chen, Melanie Kjarsgaard, Chynna Huang, John-Paul Oliveria, Paul M. O'Byrne, Gail M. Gauvreau, Louis-Philippe Boulet, Catherine Lemiere, James Martin, et al.